{"id":"https://openalex.org/W2990212836","doi":"https://doi.org/10.1210/clinem/dgz072","title":"Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials","display_name":"Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials","alternate_titles":[],"publication_year":2019,"publication_date":"2019-11-26","ids":{"openalex":"https://openalex.org/W2990212836","doi":"https://doi.org/10.1210/clinem/dgz072","mag":"2990212836","pmid":"https://pubmed.ncbi.nlm.nih.gov/31769496"},"language":"en","primary_location":{"id":"doi:10.1210/clinem/dgz072","doi":"https://doi.org/10.1210/clinem/dgz072","is_oa":false,"landing_page_url":"https://doi.org/10.1210/clinem/dgz072","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2990212836"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://zenodo.org/record/4979739","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077027153","display_name":"Cyrus V Desouza","orcid":"https://orcid.org/0000-0001-6660-0568","observed_orcids":["https://orcid.org/0000-0001-6660-0568"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Cyrus DeSouza","raw_affiliation_strings":["University of Nebraska Medical Center, Omaha, NE, US"],"raw_orcid":"https://orcid.org/0000-0001-6660-0568","affiliations":[{"raw_affiliation_string":"University of Nebraska Medical Center, Omaha, NE, US","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004521406","display_name":"Bertrand Cariou","orcid":"https://orcid.org/0000-0002-1580-8040","observed_orcids":["https://orcid.org/0000-0002-1580-8040"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]},{"id":"https://openalex.org/I4210144168","display_name":"Institut du Thorax","ror":"https://ror.org/049kkt456","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210096427","https://openalex.org/I4210144168","https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bertrand Cariou","raw_affiliation_strings":["L\u2019Institut du Thorax, Department of Endocrinology, CHU Nantes, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"L\u2019Institut du Thorax, Department of Endocrinology, CHU Nantes, Nantes, France","institution_ids":["https://openalex.org/I3019204325","https://openalex.org/I4210144168"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101586588","display_name":"Satish K. Garg","orcid":"https://orcid.org/0000-0003-1850-279X","observed_orcids":["https://orcid.org/0000-0003-1850-279X"]},"institutions":[{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Satish Garg","raw_affiliation_strings":["Barbara Davis Center for Diabetes, University of Colorado Denver, Denver, CO, US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barbara Davis Center for Diabetes, University of Colorado Denver, Denver, CO, US","institution_ids":["https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068233206","display_name":"Nanna Leonora Lausvig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nanna Lausvig","raw_affiliation_strings":["Novo Nordisk A/S, S\u00f8borg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020470965","display_name":"Andrea Navarria","orcid":"https://orcid.org/0000-0001-8764-3073","observed_orcids":["https://orcid.org/0000-0001-8764-3073"]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrea Navarria","raw_affiliation_strings":["Novo Nordisk A/S, S\u00f8borg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034671525","display_name":"Vivian Andrew Fonseca","orcid":"https://orcid.org/0000-0002-3381-7151","observed_orcids":["https://orcid.org/0000-0002-3381-7151"]},"institutions":[{"id":"https://openalex.org/I114832834","display_name":"Tulane University","ror":"https://ror.org/04vmvtb21","country_code":"US","type":"education","lineage":["https://openalex.org/I114832834"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vivian Fonseca","raw_affiliation_strings":["Tulane University Health Sciences Center, New Orleans, LA, US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tulane University Health Sciences Center, New Orleans, LA, US","institution_ids":["https://openalex.org/I114832834"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5077027153"],"corresponding_institution_ids":["https://openalex.org/I59130452"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":1.345,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.84864616,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"105","issue":"2","first_page":"543","last_page":"556"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9959999918937683},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8700000047683716},{"id":"https://openalex.org/keywords/race-and-ethnicity","display_name":"race and ethnicity","score":0.847000002861023},{"id":"https://openalex.org/keywords/sustain-trials","display_name":"SUSTAIN trials","score":0.8040000200271606},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8040000200271606},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8820000290870667},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8370000123977661},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.890999972820282},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.8429999947547913},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.7329999804496765},{"id":"https://openalex.org/keywords/asian-patients","display_name":"Asian patients","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.8529844284057617},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.7770805358886719},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.755584716796875},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.6693745255470276},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6306142807006836},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.6239628791809082},{"id":"https://openalex.org/C2779829264","wikidata":"https://www.wikidata.org/wiki/Q21011228","display_name":"Dulaglutide","level":5,"score":0.5448442101478577},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5357970595359802},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5201740264892578},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.44648364186286926},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.42312976717948914},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.38137727975845337},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2228543758392334},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.11686363816261292},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.05811721086502075},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000099194","descriptor_name":"Semaglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005006","descriptor_name":"Ethnicity","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044469","descriptor_name":"Racial Groups","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1210/clinem/dgz072","doi":"https://doi.org/10.1210/clinem/dgz072","is_oa":false,"landing_page_url":"https://doi.org/10.1210/clinem/dgz072","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},{"id":"pmid:31769496","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31769496","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical endocrinology and metabolism","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:zenodo.org:4979739","doi":null,"is_oa":true,"landing_page_url":"https://zenodo.org/record/4979739","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"dataset"},{"id":"doi:10.5061/dryad.34tmpg4fv","doi":"https://doi.org/10.5061/dryad.34tmpg4fv","is_oa":true,"landing_page_url":"https://doi.org/10.5061/dryad.34tmpg4fv","pdf_url":"https://doi.org/10.5061/dryad.34tmpg4fv","source":{"id":"https://openalex.org/S7407051161","display_name":"DRYAD","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"pmh:oai:zenodo.org:4979739","doi":null,"is_oa":true,"landing_page_url":"https://zenodo.org/record/4979739","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"dataset"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2990212836.pdf","grobid_xml":"https://content.openalex.org/works/W2990212836.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W1899550850","https://openalex.org/W1996638018","https://openalex.org/W2029044861","https://openalex.org/W2032171588","https://openalex.org/W2034667874","https://openalex.org/W2039147128","https://openalex.org/W2045117178","https://openalex.org/W2079519649","https://openalex.org/W2109416725","https://openalex.org/W2116254891","https://openalex.org/W2135298024","https://openalex.org/W2162140339","https://openalex.org/W2259797591","https://openalex.org/W2491061016","https://openalex.org/W2497721881","https://openalex.org/W2519510391","https://openalex.org/W2572398654","https://openalex.org/W2602700371","https://openalex.org/W2604469807","https://openalex.org/W2743930068","https://openalex.org/W2766979007","https://openalex.org/W2774157762","https://openalex.org/W2783296927","https://openalex.org/W2784318050","https://openalex.org/W2787255324","https://openalex.org/W2794275614","https://openalex.org/W2801715295","https://openalex.org/W2808271763","https://openalex.org/W2808831056","https://openalex.org/W2810273436","https://openalex.org/W2898597022","https://openalex.org/W2920990119","https://openalex.org/W3004190317","https://openalex.org/W4251240079","https://openalex.org/W4292528167"],"related_works":["https://openalex.org/W3114615843","https://openalex.org/W4400094503","https://openalex.org/W4406285597","https://openalex.org/W3172988920","https://openalex.org/W2948354810","https://openalex.org/W4304693485","https://openalex.org/W2808747094","https://openalex.org/W4403148856","https://openalex.org/W4212869398","https://openalex.org/W4387996786"],"abstract_inverted_index":{"CONTEXT:":[0],"Variations":[1],"in":[2,40,111,179,192,236,241,248],"the":[3,46],"prevalence":[4],"and":[5,14,38,42,61,64,73,75,101,115,124,126,129,144,150,160,168,174,182,232,238,250],"etiology":[6],"of":[7,31,53,195],"type":[8],"2":[9],"diabetes":[10],"(T2D)":[11],"across":[12,45,172,197],"race":[13,41,173,203,255],"ethnicity":[15,43,175],"may":[16],"affect":[17],"treatment":[18,30,206],"responses.":[19],"Semaglutide":[20,81],"is":[21],"a":[22],"glucagon-like":[23],"peptide-1":[24],"analog":[25],"approved":[26],"for":[27],"once-weekly,":[28],"subcutaneous":[29],"T2D.":[32],"OBJECTIVE:":[33],"To":[34],"compare":[35],"semaglutide":[36,166,227],"efficacy":[37,128,249],"safety":[39,130,251],"subgroups":[44,204],"SUSTAIN":[47,59,65,222],"trials.":[48,67,198],"DESIGN:":[49],"Post":[50],"hoc":[51,225],"analysis":[52],"data":[54],"from":[55,118,136],"phase":[56],"3":[57],"randomized":[58],"1-5":[60,72],"7":[62],"(pooled),":[63],"6":[66],"PARTICIPANTS:":[68],"3074":[69],"subjects":[70,77,196,242],"(SUSTAIN":[71,78],"7)":[74],"1648":[76],"6).":[79],"INTERVENTIONS:":[80],"0.5":[82,167],"or":[83,87,104,256],"1.0":[84,139,169],"mg,":[85,92,97,170],"placebo,":[86],"active":[88],"comparator":[89],"(sitagliptin":[90],"100":[91],"exenatide":[93],"extended":[94],"release":[95],"2.0":[96,147],"insulin":[98],"glargine":[99],"100IU/ml":[100],"dulaglutide":[102],"0.75":[103],"1.5":[105,141],"mg).":[106],"MAIN":[107],"OUTCOME":[108],"MEASURES:":[109],"Change":[110],"hemoglobin":[112],"A1C":[113],"(HbA1c)":[114],"body":[116,151,239],"weight":[117,152,240],"baseline":[119,137],"to":[120,140,146,157,162,209],"weeks":[121],"30,":[122],"40":[123],"104,":[125],"other":[127,202],"endpoints.":[131],"RESULTS:":[132],"HbA1c":[133,237],"was":[134,153,228],"reduced":[135,154],"by":[138,155],"percentage":[142,148],"points":[143],"1.3":[145],"points,":[149],"2.3":[156],"4.7":[158],"kg":[159,164],"3.6":[161],"6.1":[163],"with":[165,230,243,245,254],"respectively,":[171],"subgroups.":[176],"Minor":[177],"changes":[178],"blood":[180],"pressure":[181],"lipid":[183],"profiles":[184],"were":[185,190,216],"observed.":[186],"Adverse":[187],"events":[188],"(AEs)":[189],"reported":[191,214],"similar":[193],"proportions":[194],"More":[199],"Asian":[200],"versus":[201],"discontinued":[205],"prematurely":[207],"due":[208],"AEs.":[210],"The":[211],"most":[212],"commonly":[213],"AEs":[215],"gastrointestinal":[217],"disorders.":[218],"CONCLUSIONS:":[219],"In":[220],"this":[221],"trials":[223],"post":[224],"analysis,":[226],"associated":[229,253],"consistent":[231],"clinically":[233],"relevant":[234],"reductions":[235],"T2D,":[244],"minor":[246],"variations":[247],"outcomes":[252],"ethnicity.":[257]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2990212836","counts_by_year":[{"year":2026,"cited_by_count":15},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2019-12-05T00:00:00"}
